Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HeraMED Ltd. ( (AU:HMD) ) has shared an update.
HeraMED Limited has scheduled its Annual General Meeting for 21 May 2026 at 9:00am AEST, and has set 9 April 2026 as the deadline for shareholders or other eligible parties to submit director nominations. The timing formalises the company’s governance calendar and signals an upcoming opportunity for investors to influence the board composition as HeraMED advances its digital maternity care strategy.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
HeraMED Limited is an innovative medical data and technology company focused on digitally transforming maternity care. It offers a hybrid maternity care platform built around its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, alongside its HeraCARE ecosystem, which leverages cloud computing, artificial intelligence and big data to enhance prenatal and postpartum care for expectant mothers and healthcare providers.
YTD Price Performance: 27.78%
Average Trading Volume: 858,045
Technical Sentiment Signal: Buy
Current Market Cap: A$51.35M
See more data about HMD stock on TipRanks’ Stock Analysis page.